Clearside Biomedical Inc
NASDAQ:CLSD

Watchlist Manager
Clearside Biomedical Inc Logo
Clearside Biomedical Inc
NASDAQ:CLSD
Watchlist
Price: 1.015 USD -1.46% Market Closed
Market Cap: 77m USD

Wall Street
Price Targets

CLSD Price Targets Summary
Clearside Biomedical Inc

Wall Street analysts forecast CLSD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLSD is 6.12 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
398% Upside
Average
Price Target
6.12 USD
503% Upside
Highest
Price Target
8.4 USD
728% Upside
Clearside Biomedical Inc Competitors:
Price Targets
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
39% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
26% Upside
4502
Takeda Pharmaceutical Co Ltd
10% Upside
PPLPHARMA
Piramal Pharma Ltd
38% Upside
000513
Livzon Pharmaceutical Group Inc
9% Upside
KLBF
Kalbe Farma Tbk PT
57% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
13% Upside
086450
Dongkook Pharmaceutical Co Ltd
74% Upside

Revenue
Forecast

Revenue Estimate
Clearside Biomedical Inc

The compound annual growth rate of Clearside Biomedical Inc's revenue for the next 4 years is 30%.

N/A
Past Growth
30%
Estimated Growth
Estimates Accuracy
17%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLSD's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CLSD is 6.12 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

What is Clearside Biomedical Inc's Revenue forecast?
Projected CAGR
30%

The compound annual growth rate of Clearside Biomedical Inc's revenue for the next 4 years is 30%.

Back to Top